TY - CHAP M1 - Book, Section TI - Glaucoma A1 - Clegg, Jr., Daniel O. A2 - Chisholm-Burns, Marie A. A2 - Schwinghammer, Terry L. A2 - Malone, Patrick M. A2 - Kolesar, Jill M. A2 - Bookstaver, P. Brandon A2 - Lee, Kelly C. PY - 2022 T2 - Pharmacotherapy Principles & Practice, 6e AB - LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Identify risk factors for the development of primary open-angle glaucoma (POAG) and acute angle-closure glaucoma.Recommend a frequency for glaucoma screening based on patient-specific risk factors.Compare and contrast the pathophysiologic mechanisms responsible for open-angle glaucoma and acute angle-closure glaucoma.Outline the clinical presentation of chronic open-angle glaucoma and acute angle-closure glaucoma.List the goals of managing patients with POAG suspect, POAG, and acute angle-closure glaucoma.Choose the most appropriate therapy based on patient-specific data for open-angle glaucoma, glaucoma suspect, and acute angle-closure glaucoma.Develop a monitoring plan for patients on specific pharmacologic regimens.Counsel patients about glaucoma, drug therapy options, ophthalmic administration techniques, and the importance of adherence to the prescribed regimen. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - ppp.mhmedical.com/content.aspx?aid=1187025028 ER -